FLVCR2 and acute myeloid leukemia: Therefore, upregulated FLVCR2 probably suppresses tumor immunity, which contributes to the escape of tumor cells and promotes carcinogenesis, indicating a possible mechanism by which FLVCR2 affects the OS of patients with AML.